June 3, 2024 — Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require ...

Analyst Allen Lutz of Bank of America Securities maintained a Sell rating on GoodRx Holdings (GDRX – Research Report), retaining the ...

Dr. Troy Mensen is a family medicine doctor based in the Chicago area. He completed his undergraduate degree at the University of Northern Iowa and his doctorate at Des Moines University College ...

Elina Hypponen receives funding from the National Health and Medical Research Foundation, Medical Research Future Fund, Australian Research Council, and Arthritis Australia. Joshua Sutherland's ...

Vitamin D may help boost immune function and reduce inflammation, which could benefit people living with ulcerative colitis. However, more research is needed to fully understand the link.

RBC Capital analyst Sean Dodge maintained a Buy rating on GoodRx Holdings (GDRX – Research Report) today and set a price target of ...

Studies have linked low vitamin D with a higher risk of Alzheimer’s disease. However, it’s not clear whether vitamin D supplementation lowers Alzheimer’s risk. You can get vitamin D through ...

Vitamin D is essential for bone health, immune function and overall well-being. And it becomes even more crucial as we age. New guidelines from the international Endocrine Society recommend people ...

Magnesium and vitamin D are essential to keeping your body healthy. Both vitamin D and magnesium support physical and mental health, help to keep your bones strong, and may play a role in fighting ...

Experts agree vitamin D is the one supplement we should all be taking during autumn and winter in the UK. This is because vitamin D plays a key role in immune and bone health, and between October and ...

Your skin naturally produces vitamin D3 when exposed to the sun. Eating fish, beef, and cheese provides a natural boost of vitamin D3, too. Still, vitamin D deficiency is a common problem that can ...

GoodRx trades at a 10.2x EV/FY24 adjusted EBITDA multiple - not expensive, but also not enough of a bargain to get me off the sidelines (if multiples fell to the 5-6x range, I’d take another look).